Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01239251 · ClinicalTrials.gov registry record
GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Terminated
- Registry status
- 8
- Enrollment target
NCT01239251: Clinical Trial study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01239251 is a clinical trial that was terminated before completion, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01239251 was terminated before completion, sponsored by Memorial Sloan Kettering Cancer Center.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to test the ease of using a new device, called the GlowCap that reminds the patient to take their breast cancer hormone pill. The study will collect information about the experience with this device and what the patient thinks of its role in the daily pill taking routine.
Primary Outcome
\>60 years of age with early stage breast cancer.
Interventions
- OTHER GlowCap device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-11 |
Why NCT01239251 stopped before completion
NCT01239251 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which GlowCap device is the first listed.
NCT01239251 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01239251 about?
NCT01239251 is a clinical study titled "GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy". The purpose of this study is to test the ease of using a new device, called the GlowCap that reminds the patient to take their breast cancer hormone pill. The study will collect information about the experience with this device and what the patient thinks of its role in the daily pill taking routine...
What is the current status of trial NCT01239251?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2010-11. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01239251?
The interventions under investigation include: GlowCap device (OTHER).
Who is sponsoring clinical trial NCT01239251?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia